NFKB1 and renal fibrosis: Supplementation with Clu appeared to counteract this by reducing the nuclear localization of phosphorylated NFκB in AngII-induced RTECs, inhibiting NFκB activation, and downregulating AT1R levels, thereby lessening the extent of renal fibrosis (Ashton et al., 2014).